Regcor Tablets

Composition

Each tablet contains: 
Amlodipine (as besylate) ……………………………………………………………………….. 5 or 10 mg
Inactive ingredients:

Microcrystalline cellulose, calcium phosphate dibasic anhydrous, sodium starch glycolate, colloidal silicon dioxide, magnesium stearate.

Therapeutic Indications

Hypertension: 
REGCOR Tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents.
Coronary Artery Disease (CAD): 
Chronic Stable Angina: 
REGCOR Tablets are indicated for the symptomatic treatment of chronic stable angina. They may be used alone or in combination with other antianginal agents.
Vasospastic Angina (Prinzmetal’s or Variant Angina): 
REGCOR Tablets are indicated for the treatment of confirmed or suspected vasospastic angina. They may be used as monotherapy or in combination with other antianginal agents.
Angiographically Documented CAD: 
In patients with recently documented CAD by angiography and without heart failure or an ejection fraction < 40%, REGCOR tablets are indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure.